LH
Labcorp Holdings Inc.NYSEHealthcare$273.72+0.36%ClosedMarket Cap: $22.69B
As of 2026-04-06
Valuation
P/E (TTM)
25.89
PEG
1.48
P/B
2.62
P/S
1.63
EV/EBITDA
14.59
DCF Value
$367.37
FCF Yield
5.3%
Div Yield
1.1%
Margins & Returns
Gross Margin
28.2%
Operating Margin
10.7%
Net Margin
6.3%
ROE
10.3%
ROA
10.9%
ROIC
7.3%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $3.52B | 26.2% | $382.0M | $164.7M | $1.98 | $0.72 |
| FY 2025 | $13.95B | 26.8% | $1.52B | $876.5M | $10.46 | $2.88 |
| Q3 2025 | $3.56B | 28.8% | $396.6M | $261.1M | $3.12 | $0.72 |
| Q2 2025 | $3.53B | 29.7% | $394.5M | $237.9M | $2.84 | $0.72 |
| Q1 2025 | $3.35B | 28.3% | $326.0M | $212.8M | $2.52 | $0.72 |
| Q4 2024 | $3.33B | 26.9% | $216.5M | $143.4M | $1.70 | $0.72 |
| FY 2024 | $13.01B | 27.9% | $1.09B | $746.0M | $8.84 | $2.88 |
| Q3 2024 | $3.28B | 27.6% | $254.1M | $169.3M | $2.01 | $0.72 |
| Q2 2024 | $3.22B | 28.8% | $294.8M | $205.3M | $2.44 | $0.72 |
| Q1 2024 | $3.18B | 28.2% | $321.3M | $228.0M | $2.69 | $0.72 |
| Q4 2023 | $3.03B | 27.1% | $-122.8M | $-167.1M | $-1.97 | $0.72 |
| FY 2023 | $12.16B | 27.7% | $725.6M | $418.0M | $4.77 | $2.88 |